ObsEva Delivers...

ObsEva SA (OBSV), which disclosed positive top line results from its phase III trial of fertility treatment Nolasiban in February, has reported encouraging additional data.

from RTT - Biotech https://ift.tt/2IAzlps
via IFTTT